1. |
Klatskin G. Adenocarcinoma of the hepatic duct atits bifurcation within the porta hepatis. An unusual tumor with distinctive clinical and pathological features[J]. Am J Med, 1965, 38:241-256.
|
2. |
Saxena A, Chua TC, Chu FC, et al. Improved outcomes after aggressive surgical resection of hilar cholangiocarcinoma:a critical analysis of recurrence and survival[J]. Am J Surg, 2011, 202(3):310-320.
|
3. |
唐文皓, 唐健雄, 袁祖荣.肝门部胆管癌的治疗现状[J].国际外科学杂志, 2012, 39(5):296-298.
|
4. |
Zhimin G, Noor H, Jian-Bo Z, et al. Advances in diagnosis and treatment of hilar cholangiocarcinoma-a review[J]. Med Sci Monit, 2013, 19:648-656.
|
5. |
Gavrilovici V, Grecu F, Seripcariu V, et al. Classification and staging systems for hilar cholangio-carcinoma (Klatskin tumors):clinical application and practical relevance[J]. Rev Med Chir Soc Med Nat Iasi, 2011, 115(2):412-417.
|
6. |
Suarez-Munoz MA, Fernandez-Aguilar JL, Sanchez-Perez B, et al. Risk factors and classifications of hilar cholangiocarcinoma[J]. World J Gastrointest Oncol, 2013, 5(7):132-138.
|
7. |
何效东, 董家鸿, 赵晓雷, 等.肝门部胆管癌的诊断与外科治疗[J].中华肝胆外科杂志, 2008, 14(8):582-584.
|
8. |
Marubashi S, Gotoh K, Takahashi H, et al. Prediction of the postoperative prognosis of intrahepatic cholangiocarcinoma (ICC):importance of preoperatively-determined anatomic invasion level and number of tumors[J]. Dig Dis Sci, 2013, 12.[Epub ahead of print].
|
9. |
黄志强.肝门部胆管癌外科治疗的现状与我见[J].中国实用外科杂志, 2007, 27(5):341-346.
|
10. |
张永杰.肝门部胆管癌外科治疗的术式选择及评价[J].中国实用外科杂志, 2007, 27(5):358-361.
|
11. |
王越, 侴伟平, 葛春林.肝门部胆管癌患者生存预测模型的分析[J].中国普外基础与临床杂志, 2011, 18(6):590-594.
|
12. |
Nuzzo G, Giuliante F, Ardito F, et al. Improvement in perioper-ative and long-term outcome after surgical treatment of hilar cholang-iocarcinoma:results of an Italian multicenter analysis of 440 patients[J]. Arch Surg, 2012, 147(1):26-34.
|
13. |
Lim JH, Choi GH, Choi SH, et al. Liver resection for Bismuth typeⅠand typeⅡhilar cholangiocarcinoma[J]. World J Surg, 2013, 37(4):829-837.
|
14. |
Baton O, Azoulay D, Adam DV, et al. Major hepatectomy for hilar cholangiocarcinoma type 3 and 4:prognostic factors and longterm outcomes[J]. J Am Coll Surg, 2007, 204(2):250-260.
|
15. |
Izbicki JR, Tsui TY, Bohn BA, et al. Surgical strategies in patients with advanced hilar cholangiocarcinoma (Klatskin tumor)[J]. J Gastrointest Surg, 2013, 17(3):581-585.
|
16. |
Rosen CB, Darwish Murad S, Heimbach JK, et al. Neoadjuvant therapy and liver transplantation for hilar cholangiocarcinoma:is pretreatment pathological confirmation of diagnosis necessary?[J]. J Am Coll Surg, 2012, 215(1):31-38.
|
17. |
Robles R, Sánchez-Bueno F, Ramírez P, et al. Liver transplantation for hilar cholangiocarcinoma[J]. World J Gastroenterol, 2013, 19(48):9209-9215.
|
18. |
Rosen CB, Heimbach JK, Gores GJ. Liver transplantation for cholangiocarcinoma[J]. Transpl Int, 2010, 23(7):692-697.
|
19. |
孙学军, 石景森, 何平.影响胆管癌切除术后的预后因素分析[J].中国普外基础与临床杂志, 2006, 13(1):85-88.
|
20. |
Puhalla H, Gruenberger T, Pokorny H, et al. Resection of hilar cholangiocarcinomas:pivotal prognostic factors and impact of tumor sclerosis[J]. World J Surg, 2003, 27(6):680-684.
|
21. |
何平, 石景森, 陈武科, 等.应用Cox模型分析影响胆管癌切除术后的预后因素[J].中华肝胆外科杂志, 2002, 8(4):219-221.
|
22. |
Cannon RM, Brock G, Buell JF. Surgical resection for hilar cholangiocarcinoma:experience improves resectability[J]. HPB (Oxford), 2012, 14(2):142-149.
|
23. |
Serrablo A, Tejedor L. Outcome of surgical resection in Klatskin tumors[J]. World J Gastrointest Oncol, 2013, 5(7):147-158.
|
24. |
Guglielmi A, Ruzzenente A, Campagnaro T, et al. Prognostic significance of lymph node ratio after resection of peri-hilar cholangiocarcinoma[J]. HPB (Oxford), 2011, 13(4):240-245.
|
25. |
Nagino M. Perihilar cholangiocarcinoma:a surgeon's viewpoint on current topics[J]. J Gastroenterol, 2012, 47(11):1165-1176.
|